New drug MRX1 tested in healthy volunteers for safety and absorption
NCT ID NCT06854783
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how the investigational drug MRX1 is processed by the body, its safety, and whether food changes its absorption. Twenty healthy adults took multiple doses of MRX1. The goal was to gather basic information, not to treat any disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PHARMACOKINETICS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nucleus Network
Melbourne, Victoria, 3004, Australia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- First human trial launches for Hemay5259: a new Extended-Release drug candidate
- Apples' hidden power: study probes how polyphenols scavenge harmful carbonyls
- New vaginal capsule aims to tackle stubborn bacterial vaginosis
- New painkiller injection could cut opioid use after chest surgery
- New heartburn drug candidate tested for heart safety in healthy volunteers
- Kava and kratom combo under the microscope: new study reveals how they interact